Our Goal: Clinical Data, Faster

 

Presage's CIVO® platform accelerates early drug development by testing microdoses of anti-cancer agents directly in a patient's tumor.

Researcher
 

We believe the most important model for understanding cancer drug efficacy is the human body.

 
 
 

CIVO Platform

The patented CIVO platform is intended to evaluate early stage anti-cancer agents and combinations.

Learn More